1. Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base 
Susan E. Combs, MA, Jacquelyn G. Hancock, BS, Daniel J. Boffa, MD, Roy H. Decker, MD, PhD, Frank C. Detterbeck, MD, Anthony W. Kim, MD 
Journal of Thoracic Oncology 
Volume 10, Issue 2, Pages (February 2015)
DOI: /JTO
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

2. FIGURE 1
Kaplan–Meier curve for overall survival by clinical stage I (A), II (B), and IIIA (C) patients by treatment, including NST, surgery alone, or surgery with NST (Surg + NST). NST, nonsurgical therapy.
Journal of Thoracic Oncology  , DOI: ( /JTO )
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

3. FIGURE 2
Kaplan–Meier curve for overall survival by Charlson–Deyo score of 0 (A), 1 (B), and 2+ (C) by treatment, including NST, surgery alone, or surgery with NST (Surg + NST). NST, nonsurgical therapy.
Journal of Thoracic Oncology  , DOI: ( /JTO )
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

4. FIGURE 3
Kaplan–Meier curve for overall survival of primary surgical treatment patients by type of surgical procedure.
Journal of Thoracic Oncology  , DOI: ( /JTO )
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

5. FIGURE 4
Kaplan–Meier curve for overall survival of lobectomy patients by pathologic stage.
Journal of Thoracic Oncology  , DOI: ( /JTO )
Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions